4-(2-氟苯基)苯酚 | 321-62-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-(2-氟苯基)苯酚
• 中文别名: 2'-氟联苯基-4-醇
• 英文名称: 2'-fluoro-[1,1'-biphenyl]-4-ol
• 英文别名: 2'-fluoro-4-hydroxybiphenyl；2-fluoro-4'-hydroxybiphenyl；4-(2'-fluorophenyl)phenol；4-(2-fluorophenyl)phenol；2'-fluoro-biphenyl-4-ol；2'-Fluor-4-hydroxy-biphenyl
• CAS: 321-62-0
• 化学式: C₁₂H₉FO
• 分子量: 188.201
• InChiKey: FEHGAYLOAATVGN-UHFFFAOYSA-N

物化性质

• 熔点：
  124-126 °C
• 沸点：
  298.4±15.0 °C(Predicted)
• 密度：
  1.196±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2907199090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-(2-Fluorophenyl)phenol
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-(2-Fluorophenyl)phenol
CAS number: 321-62-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C12H9FO
Molecular weight: 188.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-(2-氟苯基)苯酚 在 potassium tert-butylate 、 二苯基膦酰羟胺 作用下， 以 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 0.67h， 以48%的产率得到O-(2'-fluoro-[1,1'-biphenyl]-4-yl)hydroxylamine
  参考文献：
  名称：

  [EN] (4-HYDROXYPYRROLIDIN-2-YL)-HYDROXAMATE COMPOUNDS AND METHODS OF USE THEREOF
  [FR] COMPOSÉS DE (4-HYDROXYPYRROLIDIN-2-YL)-HYDROXAMATE ET LEURS PROCÉDÉS D'UTILISATION

  摘要：

  本公开涉及双功能化合物，可用作靶向泛素化的调节剂。具体而言，本公开涉及包含一端为VHL配体基团的化合物，该基团结合VHL E3泛素连接酶，另一端含有结合靶蛋白的基团，从而实现对靶蛋白/多肽的降解。还公开了VHL配体。

  公开号：

  WO2019084030A1
• 作为产物：
  描述：

  在 4-氧-2,2,6,6-四甲基哌啶-1-氧自由基 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 10.0h， 以73%的产率得到4-(2-氟苯基)苯酚
  参考文献：
  名称：

  TEMPO-mediated late stage photochemical hydroxylation of biaryl sulfonium salts

  摘要：

  使用TEMPO衍生物作为简单的氧源，在无金属条件下实现了二芳基磺酸盐的晚期光化学羟基化。

  DOI：

  10.1039/d1cc07057f

文献信息

• A convenient chemical-microbial method for developing fluorinated pharmaceuticals
  作者：Tara V. Bright、Fay Dalton、Victoria L. Elder、Cormac D. Murphy、Neil K. O'Connor、Graham Sandford

  DOI：10.1039/c2ob27140k

  日期：——

  A significant proportion of pharmaceuticals are fluorinated and selecting the site of fluorine incorporation can be an important beneficial part a drug development process. Here we describe initial experiments aimed at the development of a general method of selecting optimum sites on pro-drug molecules for fluorination, so that metabolic stability may be improved. Several model biphenyl derivatives were transformed by the fungus Cunninghamella elegans and the bacterium Streptomyces griseus, both of which contain cytochromes P450 that mimic oxidation processes in vivo, so that the site of oxidation could be determined. Subsequently, fluorinated biphenyl derivatives were synthesised using appropriate Suzuki–Miyaura coupling reactions, positioning the fluorine atom at the pre-determined site of microbial oxidation; the fluorinated biphenyl derivatives were incubated with the microorganisms and the degree of oxidation assessed. Biphenyl-4-carboxylic acid was transformed completely to 4′-hydroxybiphenyl-4-carboxylic acid by C. elegans but, in contrast, the 4′-fluoro-analogue remained untransformed exemplifying the microbial oxidation – chemical fluorination concept. 2′-Fluoro- and 3′-fluoro-biphenyl-4-carboxylic acid were also transformed, but more slowly than the non-fluorinated biphenyl carboxylic acid derivative. Thus, it is possible to design compounds in an iterative fashion with a longer metabolic half-life by identifying the sites that are most easily oxidised by in vitro methods and subsequent fluorination without recourse to extensive animal studies.

  大部分药物含有氟元素，在药物开发过程中，选择氟元素的加入位置可能是一个有益的环节。在这里，我们描述了初始实验，旨在开发一种通用方法，选择前药分子上最佳的氟化位置，以提高代谢稳定性。通过含有细胞色素P450的真菌和细菌分别对几种联苯衍生物进行转化，这些细胞色素P450模拟了体内的氧化过程，从而确定了氧化位置。随后，利用适当的铃木-宫浦偶联反应合成了氟化联苯衍生物，将氟原子置于预定微生物氧化的位置；这些氟化联苯衍生物与微生物共培养，并评估了氧化程度。结果显示，联苯-4-羧酸被Cunninghamella elegans完全转化为4′-羟基联苯-4-羧酸，但4′-氟代衍生物保持不变，证明了微生物氧化-化学氟化的概念。2′-氟代和3′-氟代联苯-4-羧酸也能被转化，但速度比未氟化的联苯羧酸衍生物慢。因此，可以通过体外方法确定最容易氧化的位置，然后进行氟化，迭代设计代谢半衰期更长的化合物，无需依赖大量的动物研究。
• [EN] COMPOUNDS AND METHODS FOR TREATING OXALATE-RELATED DISEASES<br/>[FR] COMPOSÉS ET MÉTHODES DE TRAITEMENT DE MALADIES LIÉES À L'OXALATE
  申请人：OXALURX INC

  公开号：WO2019165159A1

  公开（公告）日：2019-08-29

  Disclosed herein are compounds and compositions for modulating glycolate oxidase, useful for treating oxalate-related diseases, such as hyperoxaluria, where modulating glycolate oxidase is expected to be therapeutic to a patent in need thereof. Methods of modulating glycolate oxidase activity in a human or animal subject is also provided.

  本文披露了用于调节甘醇酸氧化酶的化合物和组合物，用于治疗与草酸盐相关的疾病，如高草酸尿症，其中调节甘醇酸氧化酶预计对需要治疗的患者具有疗效。还提供了在人类或动物主体中调节甘醇酸氧化酶活性的方法。
• Oxidation of 4-arylphenol trimethylsilyl ethers to p-arylquinols using hypervalent iodine(III) reagents
  作者：François-Xavier Felpin

  DOI：10.1016/j.tetlet.2006.11.073

  日期：2007.1

  An efficient synthesis of p-arylquinols by the oxidation of 4-arylphenol trimethylsilyl ethers with phenyliodine(III) diacetate (PIDA) is reported. This protocol greatly improved the yield of p-quinol by minimizing oligomer side products compared to the oxidation of free phenol with hypervalent iodine(III) reagents. The innocuity of phenyliodine(III) diacetate associated with the mild conditions make

  的高效合成p通过4-芳基酚三甲基甲硅烷醚与phenyliodine（III）二乙酸酯（PIDA）报道氧化-arylquinols。与使用高价碘（III）试剂氧化游离苯酚相比，该协议通过最大限度地减少了低聚物副产物，大大提高了对苯二酚的收率。与温和条件相关的苯基乙酸二碘（III）的纯净性使该方法比金属介导的氧化反应更具竞争性。对提出的反应机理进行了讨论，并将其与4-取代苯酚的普遍接受机理进行了比较，以说明产率的提高。
• Palladium-catalyzed direct arylation of phenols with aryl iodides
  作者：Rongrong Long、Xufei Yan、Zhiqing Wu、Zhengkai Li、Haifeng Xiang、Xiangge Zhou

  DOI：10.1039/c5ob00132c

  日期：——

  An efficient protocol of palladium-catalyzed direct para-arylation of unfunctionalized phenols with aryl iodides under mild conditions was reported.

  一种高效的钯催化直接对未官能化酚进行芳基碘化的方法在温和条件下被报道。
• [EN] SMARCA DEGRADERS AND USES THEREOF<br/>[FR] AGENTS DE DÉGRADATION DE SMARCA ET LEURS UTILISATIONS
  申请人：KYMERA THERAPEUTICS INC

  公开号：WO2020251971A1

  公开（公告）日：2020-12-17

  The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same for the modulation of one or more SWI/SNF-related matrix associated actin dependent regulator of chromatin subfamily A (SMARCA) and/or polybromo-1 (PB-1) protein via ubiqitination and/or degradation by compounds. The compounds are bifunctional molecules that link a cereblon-binding moiety to a ligand that binds SMARCA and/or PB1 proteins.

  本发明提供化合物、其药学上可接受的组合物，以及利用这些化合物调控一个或多个SWI/SNF相关基质相关肌动蛋白依赖的染色质亚家族A（SMARCA）和/或聚溴-1（PB-1）蛋白通过化合物的泛素化和/或降解的方法。这些化合物是双功能分子，将结合到cereblon的部分与结合到SMARCA和/或PB1蛋白的配体连接在一起。